Smith, Mitchell R.
Cleveland Clinic · The University of Texas MD Anderson Cancer Center · University of Miami · University of California, Los Angeles · Moffitt Cancer Center · University of Rochester · Stanford University
6 papers on CoChatORCID 0000-0003-1428-8765
Most cited papers
- Verified
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 6,030
- Verified
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
Smith, M. R. (2003) · Oncogene
Lymphoma Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies Research
Cited by 835
- Verified
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
Leonard, J. P., LaCasce, A. S., Smith, M. R., Noy, A., Chirieac, L. R., Rodig, S. J., Yu, J. Q., Vallabhajosula, S., Schoder, H., English, P., et al. (2012) · Blood
Lymphoma Diagnosis and TreatmentAdvanced Breast Cancer Therapies
Cited by 299
- Verified
Management of Complications of Prostate Cancer Treatment
Michaelson, M. D., Cotter, S. E., Gargollo, P. C., Zietman, A. L., Dahl, D. M., & Smith, M. R. (2008) · CA: A Cancer Journal for Clinicians
Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research
Cited by 196
- Verified
Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology
Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., Milani, R. V., Sagalowsky, A. I., Smith, M. R., Zakai, N., et al. (2010) · CA: A Cancer Journal for Clinicians
Prostate Cancer Treatment and ResearchHormonal and reproductive studies
Cited by 188
- Verified
Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
Smith, M. R., Coleman, R. E., Klotz, L., Pittman, K., Milecki, P., Ng, S., Chi, K. N., Balakumaran, A., Wei, R., Wang, H., et al. (2015) · Annals of Oncology
Bone health and treatmentsProstate Cancer Treatment and Research
Cited by 145
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free